Abstract. The interaction between estrogens and androgens, with their protective effects in bone, and parathyroid hormone (PTH), a calcitropic peptide hormone, is complex but may be better understood with murine models. The purpose of this study was to characterize skeletal phenotypes of mice deficient in estrogen receptor alpha (ERa), androgen receptor (AR, mutant tfm), or both, and determine if ERa and AR alter osteoblast differentiation and/or PTH response in vitro. Loss of ERa resulted in increased long bone length in females, but reduced length in males, suggesting loss of ERa reversed sex steroid-dependent skeletal dimorphism. The AR deficient tfm mice (genetically male but phenotypically female) had the longest bones and, similar to males, lengths were reduced with loss of ERa. Loss of AR and/or ERa resulted in a reduction in femoral bone mineral density (BMD) compared to male wildtype (WT) mice, suggesting tfm mice follow the female sex for BMD. In males or tfm mice, but not females, loss of AR and/or ERa caused a reduction in cortical width of the tibia compared to male WT mice. Reduced trabecular bone was found in tibiae of female and tfm mice versus male littermates, suggesting that tfm mice follow the female sex for trabecular bone but loss of ERa did not alter trabecular bone levels. Primary calvarial osteoblasts of male WT mice were less responsive to PTH stimulation of cAMP than all other genotypes, suggesting the female chromosomal sex and/ or loss of ERa or AR results in increased sensitivity to PTH. In conclusion, tfm mice follow the male pattern of long bone development, but imitate females in bone density and trabecular bone. Loss of ERa and/or AR results in increased osteoblast sensitivity to PTH and may explain actions of PTH noted in hypogonadal humans.
It is well accepted that estrogen deficiency is a major risk factor for osteoporosis but the role of estrogen and androgen receptors in skeletal metabolism is not as clear. Hypogonadism and delayed puberty contribute to osteopenia in men and women [1] [2] [3] [4] . Osteoporosis in hypogonadal males is associated with low plasma testosterone, estradiol and androstenedione concentrations which correlate with reduced bone density [5] . One case of a man with a mutant estrogen receptor and several cases of humans with aromatase deficiency confirm that estrogen and the estrogen receptor are critical for skeletal homeostasis; however, the mechanisms involved are poorly understood [6] [7] [8] . Recent evidence suggests that actions of sex steroids in bone may be via different mechanisms than those that impact reproductive organs [9] .
Parathyroid hormone (PTH), unlike sex steroids, is a calcitropic peptide hormone that acts directly on the skeleton to promote calcium release and on the kidney to enhance calcium reabsorption via the PTH-1 receptor (PTH-1R). PTH has both catabolic and anabolic actions in bone [10] . Recent interest has been focused on its anabolic actions due to its therapeutic potential. Intermittent PTH causes an increase in vertebral, femoral and total body mineral density in postmenopausal osteoporosis [11] . On the other hand, infusion of PTH in vivo is catabolic via increased osteoclast numbers [12] . Interestingly, suppression of sex steroids increases the skeletal responsiveness to the bone-resorbing activities of PTH in elderly men [13] .
The PTH-1R was the first PTH receptor isolated, cloned and sequenced, and is present in high numbers on osteoblasts [14] . The estrogen receptor a (ERa) and androgen receptor (AR) are also expressed in osteoblasts [15, 16] . Functional effects of androgens on osteoblastic cell proliferation and alkaline phosphatase have been described [17] . Furthermore, androgens, as well as estrogens, act directly on human bone cells to selectively modulate early effects of PTH [18, 19] . Still, Correspondence to: L. K. McCauley; E-mail: mccauley@ umich.edu relationships between PTH and sex steroids are unclear.
To better understand the effects of estrogens, androgens, and their receptors in the skeleton, animal models of receptor deficiency are valuable tools. The testicular feminized male (tfm) mouse has a single point mutation in the AR that inactivates the receptor resulting in a genetically male mouse with a female phenotype [20, 21] . The AR is considered necessary for full skeletal growth and it has been suggested that a modest increase in estrogens in androgen-resistant animals may prevent cancellous bone loss [22] . Genetic models of estrogen receptor dysfunction have been generated and loss of the ERa appears to impact the skeleton more dramatically than the ERb [23, 24] .
The purpose of this study was to characterize the skeletal phenotypes of ERa, AR and combined ERa/ AR knockout mice and to determine whether ERa and AR regulate osteoblast differentiation in vitro. Further, whether these receptors are necessary for actions of PTH on osteoblasts in vitro was determined.
Materials and Methods

Generation of ERa and AR Mutant Mice
The generation of the ERa mutant mice has been described previously [25] . Heterozygous ERa +/) male and female mice were crossed to yield a Mendelian distribution of ERa +/+, +/) and )/) mice. Genotyping of tail-biopsy DNA was performed by PCR using standard protocols as described [25] . Tfm carrier female mice were obtained from the Jackson Laboratory (Bar Harbor, Maine, USA). Tfm carrier females were crossed with tabby males (The Jackson Laboratory) to continue producing tfm carriers used to obtain tfm mice. In order to generate tfm ERa-/-mice, male ERa+/) mice were crossed with tfm carrier females. The resulting ERa+/) tfm carrier females were crossed with male ERa+/) mice to get mice with the desired genotypes. Male and female littermates were used as controls. All studies were approved by the Institutional Animal Care and Use Committee at the University of Michigan.
Gross Evaluation and Microradiographic Analysis
The length and width of femurs and tibiae were measured using an electronic digital caliper (Max-Cal, MFG. Co., Ltd, Japan) with length reported as the longest measurement from proximal to distal and the width as the narrowest measurement at the mid-diaphyseal region. Femurs were evaluated using a microradiography system (Faxitron X-ray Corporation, IL, USA).
Dual Energy X-ray Absorptiometry (DEXA)
Mice were sacrificed at 4 and 12 weeks of age, and femurs and tibiae were dissected and placed in 70% ethanol for DEXA and 10% formalin for histomorphometry. Areal bone mineral density (BMD) and bone mineral content (BMC) were measured with the Norland pDEXA Sabre (Fort Atkinson, WI, USA) using the Sabre Small Animal Research software (version 2.2.4) as previously described [26] .
Bone Histomorphometry
Tibias and lumbar vertebrae from mice were trimmed of musculature, fixed in 10% formalin at 4°C, decalcified in 10% EDTA (pH 7.4) for 7 days and embedded in paraffin. Longitudinal sections of tibiae and vertebrae were cut at 5 lm and stained with hematoxylin and eosin for histological evaluation. Histomorphometric analysis of the lumbar vertebrae and tibiae were performed using a computer-assisted bone histomorphometric analyzing system (Image-Pro Plus version 4.0, Media Cybernetics, MD, USA) as described [26] . Lumbar vertebrae measurements included total area (Tt.Ar.), and percent of trabecular bone area (Tb.Ar./Tt.Ar.). Measurements of the proximal tibia were performed as described for vertebrae and also included cortical bone width (Ct.Wi.) (10 measures of cortical width taken at the mid-diaphysis were averaged for each tibia), osteocyte number (N.Ot./mm 2 ) and extension of trabeculae from the growth plate as percent of trabecular length (Tb.Le./Tt.Le) [27] .
Bone Ashing and Calcium Assay
Femurs were isolated, dried at 110°C overnight and weighed. Bones were then ashed at 800°C for 4 hours, weighed again, dissolved in 500 ll 6 N HCl, and amount of calcium was determined by colorimetric assay with cresolphthalein complexone (Sigma, St. Louis, MO, USA). Total calcium was expressed as percent of ash weight.
Isolation of Primary Calvarial Osteoblasts and Cell Culture
Primary calvarial cells were isolated as previously described [28] . Briefly, calvaria of 12 week mice were dissected, isolated from periosteum and subjected to sequential digestion of 20, 40 and 90 minutes in collagenase A (2 mg/ml, BoehringerMannheim, Indianapolis, IN, USA) with 0.25% trypsin (Invitrogen, Grand Island, NY, USA). Cells from the third digestion were washed, counted, and plated in phenol red-free a-MEM (Invitrogen) with 10% charcoal/dextran treated fetal bovine serum (HyClone, Logan, Utah, USA) containing 100 units/ml of penicillin and 100 lg/ml streptomycin. Medium was changed every other day. Primary cultures without passage were used for adenylyl cyclase stimulation and osteoblast differentiation assays.
Adenylyl Cyclase Stimulation Assay
The adenylyl cyclase stimulation and cAMP-binding protein assay were performed as previously described with minor modifications [29] . Cells were plated in triplicate at 40,000 cells/ cm 2 into 24-well plates and adenylyl cyclase stimulation assay was performed on day 7 to optimize PTH-1R expression [28] . Cells were then stimulated with 10 )8 M human PTH (hPTH) (1-34) (Bachem, Inc., Torrance, CA, USA), 10 )7 M 17-b estradiol (Sigma, St. Louis, MO, USA), or vehicle, in calcium and magnesium-free Hanks' Balanced Salt Solution (Life Technologies, Carlsbad, CA, USA) containing 0.1% bovine serum albumin and 1 mM isobutylmethylxanthine at 37°C for 15 minutes. After aspirating the medium, the cAMP was extracted by adding 250 ll/well ice-cold 5% perchloric acid and incubating overnight at )20°C. After thawing, the pH was adjusted to 7.5 with 4 N KOH, and the neutralized extract was then assayed for cAMP using a cAMP-binding protein assay [29] .
The cAMP binding assay was performed by incubating [ 3 H]-cAMP (ICN, Irvine, CA, USA) with standards or unknowns and a cAMP-binding protein sufficient to bind 40-60% of radioactivity for 90 minutes on ice. Dextran-coated charcoal was added for 20 minutes and centrifuged to remove unbound from bound cAMP-binding protein-[
3 H]-cAMP complexes. The radioactivity of the supernatants was determined with a liquid scintillation counter and cAMP levels calculated by the loglogit method using the Graph Pad Prism program. The cAMP levels were standardized to cell numbers obtained by trypan blue enumeration of parallel triplicate wells.
Mineralization Assays
Primary osteoblasts from mice of each genotype were plated in 6o mm plates and medium was changed every other day. At day 7, plates were treated with mineralization media [ascorbic acid (50 lg/ml) + b-glycerophosphate (10 mM)] for 21 days. Cells were then fixed with 95% ethanol and stained with silver nitrate by the Von Kossa method to detect phosphate deposits in bone nodules [30] , Bone nodules were analyzed morphometrically by scanning five random sites from each plate using Image-Pro Plus version 4.0. Values of mineralized nodule number per area and area of mineralization per area were calculated for primary cultures from each mouse and averaged with values from mice with the same genotype.
Statistical Analysis
The results of multiple experiments were analyzed using ANOVA followed by a Tukey-Kramer multiple comparison test and Student's t test with the Instat 2.1 biostatistics program (GraphPad Software).
Results
Gross Evaluation and Microradiographic Analysis
Mutations in ER have been speculated to be responsible for delay in epiphyseal closure, which increases long bone length [6] . To understand the impact of ERa and/ or AR in long bone development, 4-and 12-week-old tfm mice with their female and male littermates were evaluated. Gross evaluation of femurs revealed that in 12-week-old mice, loss of ERa resulted in reduced femur length in males. The tfm ERa+/+ mice had the greatest femur length, and similar to males, lengths were reduced with loss of ERa (Table 1 ). In contrast, loss of ERa caused an increase in tibia length in females.
There was a 23% increase in femur length of female and male mice during the period of growth from 4 to 12 weeks. The tfm mice had a similar but slightly lower 22% increase in femur length during this time period. In contrast, the tibiae lengths increased only 14 and 16% in female and males, respectively, and 15% in tfm mice between 4 and 12 weeks (data not shown). These data suggest that sex steroids that are typically produced increasingly from the age of 4 wks in mice may impact femur growth more than tibia growth. This appears to be true for male and tfm mice, both of which demonstrated significant reductions in femur length with loss of the ERa but nonsignificant or only mildly significant reductions in tibia length. In contrast, the trend towards increased long bone length with loss of ERa in females was significant in tibia but not femurs.
Dual X-ray Absorptiometry
Developmental studies have tried to explain the role of sex steroid receptors in the skeleton. The impact of ERa was reported in orchidectomized male mice where it was proposed that AR had a significant role as well as ERa [31] . To clarify the impact of these receptors on bone content, BMD and BMC were measured on whole femurs and tibias for all mice. Younger mice (4 weeks) demonstrated a significant increase in BMD in tfm ERa+/+ compared to ERa+/+ males and females (data not shown). However, at 12 weeks of age the female gender and loss of ERa and/or AR resulted in a reduction in BMD for femurs compared to male WT mice. Further, absence of ERa in tibiae resulted in a statistical reduction of BMD in males (Table 2) . When comparing between 4 and 12 weeks of age, femur BMD increased 13% in males but only 3% in females, suggesting that males may be more susceptible to hormonal changes during this period of growth.
Bone Histomorphometry
Previous reports of bone histomorphometry in tfm rats indicated no differences in cancellous bone volume of (17) 0.032 ± 0.0010 0.026 ± 0.0006 Male ERa) (11) 0.030 ± 0.0004* 0.025 ± 0.0002* tfm ERa+ (11) 0.029 ± 0.0005* 0.025 ± 0.0004 tfm ERa) (10) 0.028 ± 0.0005* 0.025 ± 0.0006 * p < 0.05 vs. male ERa+ the proximal tibia compared to normal female and male rats, suggesting that the AR is not critical for bone volume [22] . In contrast, ERa was shown to protect trabecular bone development in gonadectomized male mice suggesting the ERa has protective effects in the skeleton [31] . Accordingly then, the ERa and AR would appear to have different effects on the skeleton. Static histomorphometric analysis of lumbar vertebrae indicated that tfm mice had the greatest overall vertebral area and loss of ERa in the tfm background, resulting in a reduction in total vertebral area (Fig. 1A, B) . A significant reduction in trabecular area of the vertebrae was noted in the absence of ERa in female and tfm mice compared to male ERa mice but not when compared to same gender wildtype mice (Fig. 1C) .
Histomorphometry of the proximal tibias showed reduced trabecular bone for female mice compared to males. Tfm ERa +/+ mice had similar trabecular bone as females and also had reduced trabecular bone compared to male ERa+/+ mice. Loss of ERa in the tfm mice did not alter bone area versus the tfm ER a+/+ but bone area was reduced compared to ER a)/) males (Fig. 2) . When evaluating the extension of trabecular bone into the diaphysis, a similar pattern emerged. Male ERa+/+ or )/) mice had increased extension of trabeculae as compared to its tfm or female counterpart.
Male mice had the greatest tibial cortical width of all genotypes (Fig. 3) . Loss of ERa and/or AR caused significant reduction in the cortical width of males, but compared to females or tfm mice, the male ER a)/) cortical width was still higher. Osteocyte density followed a similar trend, with the lowest density found in the tibial cortical bone of female WT mice, whereas tfm ERa+/+ mice had the highest number of osteocytes.
Bone Ashing and Calcium Assay
The femoral ashweight generally paralleled the BMD levels found, with the exception that no significant difference was noted in the tfm ER a+/+ versus the male ER a+/+ (Fig. 4) . Moreover, there was no significant difference in total calcium amount and total calcium expressed as percent of ashweight for femurs amongst any genotypes (data not shown) suggesting that there were no alterations in the calcium incorporation in bone.
Mineralization Assay
Many studies have reported that estrogens and/or androgens alter osteoblast differentiation [17, 32] . In the present study, we found no significant alterations in the mineralized nodule number or area for any osteoblastic cultures from the various genotypes after 21 days of in vitro differentiation (data not shown). These data suggest that neither ERa nor AR is necessary for normal differentiation and mineralization in vitro.
Adenylyl Cyclase Stimulation Assay
PTH binds to the PTH-1R and activates adenylyl cyclase, which leads to increased cAMP production [14] . Recently it has been demonstrated that estrogens stimulate surface receptors, activate adenylyl cyclase, and stimulate cAMP production [33, 34] . To verify this effect in primary osteoblasts, 17-b estradiol was tested for its ability to stimulate adenylyl cyclase in a manner similar to PTH. The hPTH (1-34) and 17-b estradiol-treated cAMP levels were calculated relative to cell numbers and basal cAMP levels.
Results indicated a 1.5 to 2.5-fold increase in cAMP levels with 17-b estradiol but no significant difference among genotypes (data not shown). All groups demonstrated dramatic (40-200-fold) cAMP elevation following hPTH (1-34) stimulation that reflected the biological activity of PTH-1R in primary osteoblasts (Fig. 5) . Cells from female WT mice had increased PTH-stimulated cAMP levels compared to male WT where the absence of ERa and/or AR resulted in increased ability for PTH to elevate cAMP levels.
Discussion
Sex steroids exert several physiological effects on skeletal metabolism, including effects on longitudinal bone growth, bone mineral density, and composition of bone [35] . These effects of estrogens and androgens may be through direct stimulation of ERs and the AR, respectively. Further, androgens may express their actions indirectly by aromatization of androgens into estrogen, followed by the stimulation of ERs. Extensive work has been performed with animals to explain these effects of androgens and estrogens on skeletal metabolism [23, 36, 37] .
In the present study, tfm ERa mutant mice displayed altered phenotypes in bone. Previous reports demonstrated a decrease or no change in long bone length for male and female ERa knockout mice [26, 38, 39] . We found no statistical difference in femur length in the absence of ERa in female mice. Our results for male femur length were consistent with other studies, which show a reduction in the absence of ERa [40, 41] or aromatase [42] . Moreover, tfm mice had the longest femurs compared to both male and female WT and ERa knockout mice, which was different from a previous study [22] , where tfm rats had intermediate femur length between male and female littermates. An interesting finding in our study was an increase in tibia length of female ERa knockout, but not male ERa knockout mice. It has been speculated that increased femur and tibia size in females is due to delayed epiphyseal fusion since estrogen induces epiphyseal maturation [2] . In human cases, estrogen receptor mutations lead to a delay in epiphyseal closure with a resultant increase in the length of bone [6] . Hence, estrogen may be significant in limiting long bone development. In the rat model, the tibia increases in length at a more rapid rate in males than in females and gonadectomy reverses this sexual dimorphism, an effect that can be blocked by the administration of exogenous sex steroids [43] . Zhang et al. [44] reported that ovariectomy allowed appendicular growth to continue and orchidectomy resulted in a reduction in both appendicular and axial skeletal development [44] .
Our data suggest that lack of ERa in females is not critical before 12 weeks. Since sex hormones start to increase at puberty they may not show their effects until this later age where estrogen inhibits long bone length. Similarly, aromatase-deficient male mice, but not females, show an absence of accelerated growth during puberty [42] . Taken together, we propose that loss of ERa may reverse sex steroid-dependent skeletal dimorphism for adult females. ERa is necessary for appendicular development in males and is the mediator of estrogenic effects on growth and maturation of the skeleton for males [40] . Loss of ERa causes a significant reduction in longitudinal growth for tfm, hence tfm mice appear to follow the male phenotype in the appendicular skeleton. The contrast in findings of ERa loss of function in mice with the human condition are still an enigma but may be attributable to differences in timing of growth plate closure which occurs relatively later in life in mice.
It is clear that orchidectomized rodents and hypogonadal humans develop osteopenia [2, 4] . After androgen replacement therapy, bone mass is restored in gonadectomized male rats, and estrogen has reversed bone loss in adult orchidectomized rats [45, 46] . Recently, Lindberg et al. [31] showed that daily 17-b estradiol injections increased trabecular bone values in orchidectomized adult male WT and ERb knockout mice, which suggests that estrogen shows its protective effects on trabecular bone via ERa. They also proposed that in addition to ERa, the AR has equal importance in the regulation of trabecular bone. In our study, we also speculate that both ERa and AR have importance in skeletal metabolism. The DEXA data support our previous results of femur BMD and are in agreement with Vidal et al. [39, 40] that male WT mice have the highest femur BMD and BMC. After orchidectomy, adult male mice given estrogen have increased BMD and BMC values in male WT and ERb knockout mice [31] .
In our study, when ERa and/or AR were deleted, femur BMD decreased significantly which supports the notion that sex steroids exert important effects on the skeleton via ERa as well as AR in males. For adult female and tfm mice, loss of ERa does not significantly have an impact on femur and tibia BMD compared to their WTs. The tfm mice seem to imitate the female gender for BMD. Further, at 4 wks of age, femurs from tfm mice had higher BMD compared to males and females (data not shown). However, by 12 weeks, femur BMD of males started to increase compared to tfm and females. This increase between the age of 4 and 12 weeks was much greater for males than females. This finding is in agreement with Vidal et al. [40] who stated that ERawas an important mediator of estrogenic effects on the maturation of the skeleton in male mice.
Previously, Vanderschueren et al. [22] reported that tfm mice had lower vertebral ashweight than male littermates. In the present study, there was a significant reduction in femur ashweight with the loss of ERa but not AR compared to male WT. Interestingly, in tfm ERa)/) mice, femur ashweight decreased significantly compared to male WT and tfm ERa+/+, which may indicate that loss of ERa causes a reduction in the mineral content of long bones. According to these changes, tfm mice follow a similar pattern as males for skeletal mineral content.
Recent interest has focused on receptor knockout models as well as gonadectomy models, in which the effects of sex steroids on trabecular bone have been reported. Treatment with estrogen was shown to prevent the reduction in trabecular BMD and histomorphometric parameters of bone in adult orchidectomized WT compared to ERa knockout males [31] . The ERa has also been reported to be critical for the stimulatory action of high dose estrogen on cancellous bone formation [47] .
Turner et al. [48] reported that orchidectomy did not alter static bone histomorphometry measurements whereas ovariectomy increased cross-sectional areas of tibiae, and either orchidectomy or ovariectomy reduced trabecular area and trabecular bone length of tibiae in 4-week-old rodents. Lindberg et al. [31] also concluded that ERa protects trabecular bone loss in male mice and that there is redundancy with AR in the regulation of trabecular bone. In contrast, our ERa knockout mice did not show any significant alterations in amount of trabecular bone of the tibiae when compared to their wildtype counterparts. Further, Vanderschueren et al. demonstrated that tfm female rats had no difference in cancellous bone volumes for tibial histomorphometric analysis than male rats [22] . However, we found significantly decreased tibial trabecular bone area and trabecular bone length compared to male littermates. These results may indicate that tfm mice follow the female gender for trabecular bone. The impact of ERa and/or AR on skeletal development as compared to wildtype mice are summarized for male/tfm and female/tfm mice in Tables 3 and 4 , respectively. In general, changes are more dramatic for male mice than for female mice. In female mice, loss of the AR has more impact than loss of ERa or the combination of AR and ERa. In male mice, loss of AR or ERa impacts the skeleton with opposing effects on femur length but similar detrimental effects on bone mineral density and cortical bone. In the present study, numbers of osteocytes were elevated in female ERa)/) versus wildtype mice and also in tfm mice. Recently, it has been proposed that osteocytes play a role in inhibiting bone remodeling [49] . Since previous reports have indicated that loss of ERa results in decreased bone remodeling [38] , our data are in concert with this and suggest that loss of the AR may also have the same impact on bone remodeling, however, an in depth analysis of dynamic parameters is needed to verify this. Loss of ERa did not have an impact on trabecular bone whereas loss of AR resulted in reduced trabecular bone in the tibia but not in the vertebrae. According to these results it appears that the impact of ERa and AR are more detrimental for males than females.
In order to better understand the cellular and molecular actions of ERa and AR in bone, an in vitro evaluation of osteoblastic differentiation and receptor function was made. It is established that steroid hormones exert their effects by binding to their nuclear receptors in osteoblasts. This classic estrogen receptorsignaling pathway occurs through the entry of estrogen into the cell, interaction with ER, and transcriptional activation of estrogen-responsive genes. Recently, it has been speculated that estrogen and growth factors might share the same pathway in their signaling via plasma membrane receptors [34, 50, 51] . One of these studies reported that estrogen was found to increase cAMP in breast cancer and uterine cells as detected by enhanced membrane adenylate cyclase activity. Others have demonstrated activation of the MAPK pathway in bone or osteoblastic cells by estrogen and that this action is likely mediated through a plasma membrane receptor [51, 52] . Our results showed that 17-b estradiol induced cAMP 1.5-2.5-fold in primary osteoblasts, a result similar among all six genotypes, suggesting that the ER or AR had no impact on this cell surface effect.
It has been suggested that sex steroids induce osteoblastic differentiation via their receptors, ERa and AR, in bone cells in vitro [17, 32, 53] . In our study, primary osteoblasts demonstrated mineralized nodule formation; however, there was no significant difference in nodule formation from cells of the different genotypes, indicating that loss of ERa and/or AR does not modify osteoblastic nodule formation in the absence of sex steroid hormone.
It is also clear that both in vitro and in vivo PTH stimulates cAMP and c-fos, which are early events in the PTH signaling cascade [54] . In human trials, intermittent administration of PTH (1-34) is anabolic and increases bone density in both men and women with osteoporosis [11, 55] . However, in hypogonadal men, infusion of PTH (1-34) caused a significant increase in bone-resorbing markers but did not affect bone formation markers [13] . In our study, primary osteoblasts with ablation of ERa and/or AR and from female WT mice had higher PTH (1-34) cAMP levels than male WT mice. We can speculate that the female chromosomal sex and loss of ERa and/or AR resulted in an increased sensitivity to PTH.
In summary, these data suggest that tfm mice follow the male pattern for appendicular skeletal development, but imitate the female sex in bone density and trabecular bone. Further, loss of ERa and/or AR result(s) in increased osteoblastic sensitivity to PTH and may explain the actions of PTH noted in hypogonadal humans. These models will help to understand the altered mechanisms of skeletal metabolism, and may facilitate improved therapeutic approaches for the treatment of hypogonadal-associated osteoporosis.
